{"id":"placebo-for-genakumab","safety":{"commonSideEffects":[{"rate":"null","effect":"Injection site reaction"},{"rate":"null","effect":"Headache"},{"rate":"null","effect":"Fatigue"}]},"_chembl":{"chemblId":"CHEMBL521875","moleculeType":"Small molecule","molecularWeight":"460.53"},"_fixedAt":"2026-03-30T12:16:09.904915","_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"As a placebo, genakumab placebo does not interact with any molecular targets or biological pathways. It is used as a control in clinical trials to compare the efficacy of the active drug.","oneSentence":"This drug is a placebo, meaning it has no active pharmacological effect.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:27:10.347Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Rheumatoid Arthritis"}]},"_fixedFields":["modality→Monoclonal Antibody"],"trialDetails":[{"nctId":"NCT05894148","phase":"PHASE1","title":"Clinical Study of Multiple Dose Genakumab for Injection in Chinese Healthy Adults","status":"COMPLETED","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2023-03-06","conditions":"Interstitial Lung Disease","enrollment":24},{"nctId":"NCT05328531","phase":"PHASE1, PHASE2","title":"Clinical Study of Genakumab for Injection in Patients With Acute Gout","status":"COMPLETED","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2021-05-22","conditions":"Acute Gout","enrollment":121},{"nctId":"NCT05983445","phase":"PHASE3","title":"Safety & Efffficacy of Genakumab in Patients With Frequent Flares","status":"COMPLETED","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2023-01-11","conditions":"Acute Gout Arthritis","enrollment":313},{"nctId":"NCT04337437","phase":"PHASE1","title":"Clinical Study of Genakumab for Injection in Chinese Healthy Volunteers","status":"UNKNOWN","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2019-04-22","conditions":"Juvenile Idiopathic Arthritis","enrollment":40}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"placebo for genakumab","genericName":"placebo for genakumab","companyName":"Changchun GeneScience Pharmaceutical Co., Ltd.","companyId":"changchun-genescience-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This drug is a placebo, meaning it has no active pharmacological effect. Used for Rheumatoid Arthritis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}